CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.3 CNY | +4.35% |
|
+26.01% | -6.69% |
| Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
| Apr. 02 | Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. | CI |
| Sales 2022 | 2.44B 337M | Sales 2023 | 2.11B 292M | Capitalization | 32.07B 4.43B |
|---|---|---|---|---|---|
| Net income 2022 | 553M 76.39M | Net income 2023 | 367M 50.69M | EV / Sales 2022 | 12.5 x |
| Net cash position 2022 | 5.17B 714M | Net cash position 2023 | 3.61B 499M | EV / Sales 2023 | 13.5 x |
| P/E ratio 2022 |
64.5
x | P/E ratio 2023 |
87.3
x | Employees | 2,324 |
| Yield 2022 |
0.29% | Yield 2023 |
-
| Free-Float | 33.14% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.35% | ||
| 1 week | +26.01% | ||
| Current month | +16.22% | ||
| 1 month | +16.22% | ||
| 3 months | +9.76% | ||
| 6 months | -2.68% | ||
| Current year | -6.69% |
1 week
39.89
53.87
1 month
37.5053.87
Current year
37.5055.53
1 year
37.5067.00
3 years
37.50137.14
5 years
37.50141.43
10 years
37.50141.43
| Managers | Title | Age | Since |
|---|---|---|---|
Xiu Cai Liu
CHM | Chairman | 67 | 19-08-17 |
Wen Ying Yang
DFI | Director of Finance/CFO | - | - |
Chen Yang
COO | Chief Operating Officer | 40 | 19-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
William Keller
BRD | Director/Board Member | 75 | 19-08-17 |
Joachim Rudolf
BRD | Director/Board Member | 63 | 19-08-17 |
Xiu Cai Liu
CHM | Chairman | 67 | 19-08-17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -9.04% | - | |
| 0.81% | 45 M€ | -10.92% | - | |
| 0.81% | 45 M€ | -11.04% | - | |
| 0.81% | 39 M€ | -9.15% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 51.3 | +4.35% | 8,711,239 |
| 24-04-29 | 49.16 | +12.99% | 6,058,852 |
| 24-04-26 | 43.51 | +5.58% | 2,896,819 |
| 24-04-25 | 41.21 | +2.11% | 1,363,726 |
| 24-04-24 | 40.36 | -0.71% | 835,539 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
2024-08-07
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.69% | 3.96B | |
| +4.72% | 26.02B | |
| +11.09% | 1.73B | |
| -18.40% | 583M | |
| -17.62% | 409M | |
| -81.65% | 216M |
- Stock Market
- Equities
- 688065 Stock
